Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amgen Inc Raises FY 2013 Guidance


Tuesday, 22 Oct 2013 04:02pm EDT 

Amgen Inc announced that for fiscal 2013, it expects total revenues to be in the range of $18.3 billion to $18.5 billion and adjusted EPS to be in the range of $7.35 to $7.45. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $18.3 billion and EPS of $7.32 for fiscal 2013. 

Company Quote

163.46
2.79 +1.74%
26 Dec 2014